Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
09 April 2019Website:
http://telomirpharma.comNext earnings report:
30 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 01 Jul 2024 22:30:19 GMTDividend
Analysts recommendations
Institutional Ownership
TELO Latest News
Commences the study, The Safety of Telomir-1 when Administered Orally to Geriatric Laboratory Beagle Dogs for 63 Consecutive Days study to evaluate the safety of Telomir-1 on geriatric canines
Telomir Pharmaceuticals plans to raise $7 million through an IPO to fund its development of treatments for age-related inflammatory conditions. The company's lead candidate, TELOMIR-1, has the potential to act as an Interleukin-17 inhibitor for conditions such as hemochromatosis and osteoarthritis. Given TELO's thin capitalization, high valuation expectations and early stage of development, my opinion on the IPO is to Sell [Avoid].
What type of business is Telomir Pharmaceuticals Common Stock?
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. It develops TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic intervention against age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, as well as for post-chemotherapy recovery by interrupting and preventing the interleukin-17 induced inflammatory pathways. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. on October 10, 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Baltimore, Maryland.
What sector is Telomir Pharmaceuticals Common Stock in?
Telomir Pharmaceuticals Common Stock is in the Healthcare sector
What industry is Telomir Pharmaceuticals Common Stock in?
Telomir Pharmaceuticals Common Stock is in the Biotechnology industry
What country is Telomir Pharmaceuticals Common Stock from?
Telomir Pharmaceuticals Common Stock is headquartered in United States
When did Telomir Pharmaceuticals Common Stock go public?
Telomir Pharmaceuticals Common Stock initial public offering (IPO) was on 09 April 2019
What is Telomir Pharmaceuticals Common Stock website?
https://telomirpharma.com
Is Telomir Pharmaceuticals Common Stock in the S&P 500?
No, Telomir Pharmaceuticals Common Stock is not included in the S&P 500 index
Is Telomir Pharmaceuticals Common Stock in the NASDAQ 100?
No, Telomir Pharmaceuticals Common Stock is not included in the NASDAQ 100 index
Is Telomir Pharmaceuticals Common Stock in the Dow Jones?
No, Telomir Pharmaceuticals Common Stock is not included in the Dow Jones index
When does Telomir Pharmaceuticals Common Stock report earnings?
The next expected earnings date for Telomir Pharmaceuticals Common Stock is 30 August 2024